Ampio Pharmaceuticals, Inc(NYSE MKT:AMPE) 
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunology-based therapies for the treatment of prevalent inflammatory conditions in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for...
Website: http://www.ampiopharma.com
Founded: 2008
Full Time Employees: 23
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-12-28
P
O 2.42
H 2.78
L 2.26
C 2.36
V 782,175
10EMA 2.36
20EMA 2.36
60EMA 2.36
120EMA 2.36
250EMA 2.36